All Stories

  1. Challenges in harmonising terms and patterns among interstitial pneumonias: enter idiopathic bronchiolocentric interstitial pneumonia
  2. Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort Study
  3. One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease
  4. Monocyte Subset Predict Clinical Outcomes in Fibrotic Hypersensitivity Pneumonitis
  5. Psychometric Properties and Prognostic Value of the UCSD Shortness of Breath Questionnaire in Hypersensitivity Pneumonitis: A Prospective Cohort Study
  6. Rethinking the CT and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia
  7. Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease
  8. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature
  9. Alternative assays for identifying the inciting antigen in hypersensitivity pneumonitis
  10. Rationale and design of the prognostic transcriptomic signature in fibrotic hypersensitivity pneumonitis (PREDICT) study
  11. Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
  12. Uncovering the Risk of Inhalational Exposures Across Interstitial Lung Diseases
  13. Prognostic accuracy of a peripheral blood transcriptome signature in chronic hypersensitivity pneumonitis
  14. Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report − Executive Summary
  15. Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
  16. Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report
  17. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs
  18. Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
  19. Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases
  20. Soldiering on the Job When Ill: Productivity Costs in Connective Tissue Disease–associated Interstitial Lung Disease
  21. IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis
  22. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
  23. Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
  24. Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management
  25. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
  26. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
  27. Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis-Related Mortality in the United States, 1999 to 2017
  28. Reply to Hall et al.: Hypersensitivity Pneumonitis Mortality by Industry and Occupation
  29. Increasing Hypersensitivity Pneumonitis–related Mortality in the United States from 1988 to 2016
  30. The Role of Computed Tomography Honeycombing in Profiling Disease Progression in Chronic Interstitial Lung Disease
  31. Changing trends in age-adjusted pulmonary fibrosis mortality in the USA: a joinpoint regression analysis
  32. United States trends in mortality rates for primary immunodeficiency diseases
  33. IPF Look-Alikes
  34. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
  35. Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement
  36. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey
  37. Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-based Cohort Analysis
  38. An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis
  39. Presence of Air Trapping and Mosaic Attenuation on Chest Computed Tomography Predicts Survival in Chronic Hypersensitivity Pneumonitis
  40. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
  41. Refining the Burden of Idiopathic Pulmonary Fibrosis: The Cocktail Party Effect
  42. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival
  43. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease
  44. Current Approach to Diagnosis and Management of Pulmonary Eosinophilic Syndromes: Eosinophilic Pneumonias, Eosinophilic Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome
  45. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
  46. Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis
  47. Fibrotic hypersensitivity pneumonitis
  48. Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial Pneumonia
  49. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
  50. Nonasthmatic Eosinophilic Bronchitis
  51. Bronchiectasis
  52. Eosinophilic Lung Diseases
  53. Identifying an Inciting Antigen Is Associated With Improved Survival in Patients With Chronic Hypersensitivity Pneumonitis
  54. FEV1 over time in patients with connective tissue disease-related bronchiolitis
  55. Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
  56. Granulomatous Lymphocytic Interstitial Lung Disease
  57. Peeling away the layers of the volume-outcome effect and harvesting hidden connections*
  58. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease
  59. Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease
  60. Rheumatoid Arthritis and Pneumoconiosis
  61. Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death
  62. Air hunger, unwelcome guests, clogged pipes and idiopathic inflammatory myositis: Can we do better?
  63. Interpretation of airway pressure waveforms
  64. Eosinophilic Lung Diseases
  65. Increased Risk of Pulmonary Embolism Among US Decedents With Sarcoidosis From 1988 to 2007
  66. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
  67. Derivation and Diagnostic Accuracy of the Surgical Lung Injury Prediction Model
  68. Sarcoidosis-related Mortality in the United States from 1988 to 2007
  69. Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
  70. Rheumatoid Arthritis–Interstitial Lung Disease–associated Mortality
  71. Long-Term Survival and Quality of Life After Transfusion-Associated Pulmonary Edema in Critically III Medical Patients
  72. Severity of Illness and Outcome in Patients With End-Stage Idiopathic Pulmonary Fibrosis Requiring Mechanical Ventilation: Response
  73. Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
  74. Outcome of critically ill patients with influenza virus infection
  75. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
  76. Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
  77. Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study
  78. Respiratory Monitoring
  79. Interpretation of airway pressure waveforms
  80. Ventilator Settings and Outcome of Respiratory Failure in Chronic Interstitial Lung Disease
  81. The Practice of Platelet Transfusion in the Intensive Care Unit
  82. The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit
  83. Nonfamilial hemophagocytic lymphohistiocytosis
  84. Post-thoracentesis trapped lung
  85. Acute pancreatitis due to hereditary angioedema
  86. Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study
  87. Intraoperative Tidal Volume as a Risk Factor for Respiratory Failure after Pneumonectomy
  88. A case of hydrocortisone desensitization in a patient with radiocontrast-induced anaphylactoid reaction and corticosteroid allergy
  89. Interpretation of airway pressure waveforms
  90. Sepsis during pregnancy
  91. Interpretation of airway pressure waveforms